Cashu | News | SLP

HomeWatchlistNewsSignalsPicks

DJI

-0.32%

SPX

-0.01%

IXIC

+0.05%

FTSE

+0.22%

N225

-0.21%

AXJO

+1.37%

HomeWatchlistNewsSignalsPicks

Stocks

0.00 (0.00%)

0.000

USD

At close at --,----

Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.

Company

About Us
Careers
Blog
News

Help & Support

Help Center
Contact Us
Pro Support

Legal

Privacy Policy
Terms of Use

Instagram YouTube

© 2024 Cashu PTY LTD.

Join our newsletter to keep up to date with us!

Latest Simulations Plus News

Simulations Plus Sees Weaker Demand Persist, Outlook Softens

Feature Image for interests on Analyst Color, Earnings, Expert Ideas, News from benzinga.com

US Stocks Likely To Open Lower As Trump's 20% Blanket Tariff Bombshell Weighs On Markets: Bitcoin-Linked Stocks MSTR, COIN Jump As BTC Touches $123,000

Feature Image for interests on Consumer Cyclical, CryptoCurrency, Equities, Financial Services from benzinga.com

S&P 500 Records Weekly Loss Amid Trump Tariff Jitters: Fear & Greed Index Remains In 'Extreme Greed' Zone

Feature Image for interests on Basic Materials, Financial Services, Industrials, Pre-Market Outlook from benzinga.com

A Look Ahead: Simulations Plus's Earnings Forecast

GovGrants Now Available on California's Software Licensing Program (SLP) Marketplace

Feature Image for interests on Computer Software, Stock, Technology from prnewswire.com

Simulations Plus Slashes Guidance Amid Biotech Spending Cuts, Analyst Expresses Doubt

Feature Image for interests on Analyst Color, Briefs, Expert Ideas, Stock from benzinga.com

about 1 month ago

businesswire.com

Simulations Plus to Participate in Upcoming Healthcare Investor Conferences

businesswire.com

Simulations Plus and Enabling Technologies Consortium Announce Strategic Collaboration to Advance GastroPlus Enhancements

businesswire.com

Simulations Plus Supported Development of Majority of FDA-Approved Drugs in 2024

businesswire.com

Simulations Plus Supported Development of Every FDA-Approved Drug in 2024

Latest Cashu News

Simulations Plus (SLP) Faces Revenue Decline, Stays Committed to Innovation and Growth

Simulations Plus Navigates Market Sentiment to Innovate Drug Development Solutions

Simulations Plus (SLP) Awaits Key Earnings Report with Promising Growth Insights

Stocks

Health Care

slp

Simulations Plus

SLP

-0.33 (-2.58%)

12.46

USD

At close at Jul 18, 20:37 UTC